Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives.

GlaxoSmithKline plc (GSK) is a global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. It has and operations in some 114 countries, with products sold in over 140 countries. The Company... more

Coley Pharmaceutical was founded in 1997 to pursue a single goal: to develop biopharmaceuticals that build on the pioneering science of TLR stimulation to direct targeted immune responses that fight diseases. Our proprietary TLR TherapeuticsÔ drug platform is based on ground-breaking... more

Protherics is a leading biopharmaceutical company focused on developing, manufacturing and marketing critical care and cancer products. We have developed two FDA approved products in-house, CroFabÔ and DigiFabÔ. Our plan is to use revenues from our marketed products and licensing income... more

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes... more

PowderJect is the world's leading independent vaccine company. The company's headquarters are located in Oxford, UK, and it has facilities located in Europe and the US. With a range of products sold under its Evans Vaccines and SBL Vaccines brands, PowderJect is one of the world's largest... more

Antigenics Inc. is a biotechnology company focused on developing technologies and product candidates to treat cancers and infectious diseases, primarily based on immunological approaches. The Company’s principal product candidate is Oncophage (vitespen), a patient-specific therapeutic... more

CEL-SCI Corporation is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day. Multikine is multi-targeted, it is the cancer immunotherapy that both kills cancer... more

AVANT targets its efforts where it can add the greatest value to the development of its products and technologies. Our goal is to demonstrate clinical proof-of-concept for each product, and when appropriate seek excellent partners to help see those products through to commercialization.... more

Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent development programs in the areas of infectious disease and... more

VIDO is developing novel vaccine formulation and delivery systems including powerful, naturally-derived vaccine additives and needle-free methods. In a highly interdisciplinary and team-based environment, we are working to improve quality of life for animals and increase the... more

IDEC is a leader in the discovery, development, and commercialization of targeted immunotherapies for the treatment of cancer and autoimmune diseases. IDEC discovered and developed the first commercially available radioimmunotherapy product (Zevalin®) approved in the United States, which... more

Berna Biotech AG (Swiss Exchange: BBIN) develops, produces and markets vaccines and immunotherapeutics for private and public markets world-wide. Headquartered in Berne, Switzerland, with affiliates in Europe and Korea, Berna is a fully-integrated company with over 900 employees. Berna... more

About PowderMed PowderMed (http://www.powdermed.com/) is a private immunotherapeutic company based in Oxford, UK. The Company is focused on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical... more

Antigen Express has pioneered and patented novel methods to enhance antigen-specific immune responses.

ODC Therapy Inc. is a cancer vaccine company focused on providing optimal dendritic cell therapies to individual patients. ODC has licensed a portfolio of intellectual property from Baylor Research Institute and Rockefeller University in the fields of immunotherapy and immunomonitoring.... more

Starvax is a global biotech company with an R&D center in Beijing, China. Focusing on the development of novel therapeutic drugs for the treatment of infectious disease and cancer, we also offer outsourcing service to meet the fast growing demand from the biomedical research communities... more

Genitrix, LLC, a privately held biotechnology company headquartered in Cambridge, MA, is developing innovative therapeutic vaccines based on its powerful OpsonokineTM technology. OpsonokinesTM are "sticky" cytokines that attach to cells automatically, on contact, making it possible to put... more